MarketCap
Facebook
X
TelegramAnnual report 2022
added 10-07-2022
Allied Healthcare Products Total Assets 2011-2026 | AHPI
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Allied Healthcare Products
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 19.7 M | 17.7 M | 19.7 M | 15.5 M | 17.3 M | 19.6 M | 23.2 M | 25 M | 26 M | 29.3 M | 31.3 M | 31.8 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 31.8 M | 15.5 M | 23 M |
Quarterly Total Assets Allied Healthcare Products
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 16.2 M | 15.9 M | 17.1 M | 17.7 M | 18 M | 20 M | 19.7 M | 19.7 M | 16 M | 15.3 M | 15.5 M | 15.5 M | 15.5 M | 17 M | 17.1 M | 17.3 M | 17.3 M | 18.8 M | 19.4 M | 19.6 M | 19.6 M | 20.9 M | 22 M | 22.5 M | 23.2 M | 24.2 M | 24.8 M | 25 M | 25 M | 25.5 M | 26.2 M | 26 M | 26 M | 28.4 M | 29.4 M | 29.3 M | 29.3 M | 30.1 M | 31.1 M | 31.5 M | 31.3 M | 31.5 M | 31.9 M | 31.8 M | 31.8 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 31.9 M | 15.3 M | 22.8 M |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BIOLASE
BIOL
|
35.1 M | - | -13.19 % | $ 166 K |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B | USA |
 |
Globus Medical
GMED
|
5.3 B | $ 90.74 | -3.16 % | $ 12.3 B | USA |
 |
AdaptHealth Corp.
AHCO
|
4.32 B | $ 13.38 | 2.29 % | $ 1.81 B | USA |
 |
BioSig Technologies
BSGM
|
188 M | - | 37.08 % | $ 85.7 M | USA |
 |
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
659 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
62.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | USA |
 |
Cardiovascular Systems
CSII
|
323 M | - | 0.15 % | $ 844 M | USA |
 |
Electromed
ELMD
|
53.8 M | $ 25.74 | -2.28 % | $ 218 M | USA |
 |
LENSAR
LNSR
|
71.4 M | $ 5.35 | 2.69 % | $ 64 M | USA |
 |
EDAP TMS S.A.
EDAP
|
77.2 M | $ 3.28 | 1.55 % | $ 123 M |  France |
 |
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | USA |
 |
Dynatronics Corporation
DYNT
|
15.4 M | - | 14.99 % | $ 929 K | USA |
 |
Cytosorbents Corporation
CTSO
|
44.2 M | $ 0.6 | -1.96 % | $ 37.3 M | USA |
 |
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | USA |
 |
ClearPoint Neuro
CLPT
|
97.7 M | $ 11.08 | -1.16 % | $ 314 M | USA |
 |
Helius Medical Technologies
HSDT
|
7.69 M | $ 2.08 | -1.89 % | $ 1.26 M | USA |
 |
Eargo
EAR
|
132 M | - | - | $ 10.2 M | USA |
 |
Sintx Technologies
SINT
|
9.51 M | $ 2.15 | -8.51 % | $ 5.96 M | USA |
 |
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | USA |
 |
Second Sight Medical Products
EYES
|
39.4 M | - | -0.97 % | $ 54.4 M | USA |
 |
Stryker Corporation
SYK
|
47.8 B | $ 321.43 | -2.3 % | $ 123 B | USA |
 |
GBS
GBS
|
8.25 M | - | -0.57 % | $ 7.12 M | USA |
 |
Tactile Systems Technology
TCMD
|
274 M | $ 23.57 | -2.76 % | $ 539 M | USA |
 |
TELA Bio
TELA
|
81.4 M | $ 0.78 | -2.46 % | $ 36.6 M | USA |
 |
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | USA |
 |
TransMedics Group
TMDX
|
1.07 B | $ 101.26 | -6.34 % | $ 3.44 B | USA |
 |
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Tandem Diabetes Care
TNDM
|
881 M | $ 18.63 | -6.0 % | $ 1.27 B | USA |
 |
LivaNova PLC
LIVN
|
2.61 B | $ 61.29 | -3.34 % | $ 3.34 B |  Britain |
 |
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M |  Canada |
 |
Orthofix Medical
OFIX
|
851 M | $ 11.91 | -3.33 % | $ 472 M |  Curacao |
 |
PAVmed
PAVM
|
38.8 M | $ 8.94 | 6.43 % | $ 5.99 M | USA |
 |
Pulmonx Corporation
LUNG
|
129 M | $ 1.23 | -4.3 % | $ 50 M | USA |
 |
Butterfly Network
BFLY
|
256 M | $ 5.16 | -5.84 % | $ 1.09 B | USA |
 |
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
509 M | $ 15.14 | -4.3 % | $ 355 M | USA |
 |
Delcath Systems
DCTH
|
124 M | $ 10.55 | -2.68 % | $ 378 M | USA |
 |
IRIDEX Corporation
IRIX
|
29.2 M | $ 1.04 | -3.7 % | $ 17.6 M | USA |
 |
CONMED Corporation
CNMD
|
2.33 B | $ 36.79 | -2.85 % | $ 1.14 B | USA |
 |
Inspire Medical Systems
INSP
|
907 M | $ 55.11 | 0.07 % | $ 1.62 B | USA |
 |
Integer Holdings Corporation
ITGR
|
3.41 B | $ 84.64 | -0.83 % | $ 2.94 B | USA |
 |
Invacare Corporation
IVC
|
771 M | - | - | $ 24.7 M | USA |